EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 350 filers reported holding EXELIXIS INC in Q4 2020. The put-call ratio across all filers is 2.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $204,000 | -19.0% | 9,658 | -13.4% | 0.02% | -11.8% |
| Q1 2021 | $252,000 | +18.9% | 11,158 | +5.2% | 0.02% | +6.2% |
| Q4 2020 | $212,000 | -10.5% | 10,603 | +9.9% | 0.02% | -30.4% |
| Q3 2020 | $237,000 | -36.8% | 9,646 | -39.1% | 0.02% | -34.3% |
| Q2 2020 | $375,000 | +33.0% | 15,835 | +33.7% | 0.04% | +12.9% |
| Q1 2019 | $282,000 | -6.6% | 11,845 | -15.8% | 0.03% | +40.9% |
| Q2 2018 | $302,000 | +3.8% | 14,067 | +47.0% | 0.02% | +15.8% |
| Q4 2017 | $291,000 | +24.9% | 9,569 | -0.7% | 0.02% | +18.8% |
| Q3 2017 | $233,000 | -4.1% | 9,641 | -2.2% | 0.02% | -5.9% |
| Q2 2017 | $243,000 | – | 9,855 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |